Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT03984526

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03984526
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03984526. Randomized; double masking; primary purpose prevention. Start 2019-06-25 (actual); primary completion 2020-09-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients
Condition
Anesthesia, Spinal
Condition
Dexmedetomidine
Condition
Bradycardia
Intervention (Drug)
normal saline
Intervention (Drug)
atropine 0.5mg
Intervention (Drug)
ephedrine 8mg
Lead sponsor
Ajou University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct03984526
Content hash
3a07f03797bc270aeeeaf43d7770b926ce765afd3fb77117448cb2e6ee4d8496